101 related articles for article (PubMed ID: 15242569)
1. Gene therapy for thyroid cancer: current status and future prospects.
Spitzweg C; Morris JC
Thyroid; 2004 Jun; 14(6):424-34. PubMed ID: 15242569
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy in thyroid cancer.
Spitzweg C
Horm Metab Res; 2009 Jun; 41(6):500-9. PubMed ID: 19434562
[TBL] [Abstract][Full Text] [Related]
3. Gene therapeutic approaches for medullary thyroid carcinoma treatment.
Drosten M; Pützer BM
J Mol Med (Berl); 2003 Jul; 81(7):411-9. PubMed ID: 12811413
[TBL] [Abstract][Full Text] [Related]
4. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
[TBL] [Abstract][Full Text] [Related]
5. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
6. Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer.
Barzon L; Bonaguro R; Castagliuolo I; Chilosi M; Gnatta E; Parolin C; Boscaro M; Palù G
J Clin Endocrinol Metab; 2002 Nov; 87(11):5304-11. PubMed ID: 12414907
[TBL] [Abstract][Full Text] [Related]
7. Innovative strategies for the treatment of thyroid cancer.
Schmutzler C; Koehrle J
Eur J Endocrinol; 2000 Jul; 143(1):15-24. PubMed ID: 10870026
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
9. Radiochemotherapy of hepatocarcinoma via lentivirus-mediated transfer of human sodium iodide symporter gene and herpes simplex virus thymidine kinase gene.
Chen L; Guo G; Liu T; Guo L; Zhu R
Nucl Med Biol; 2011 Jul; 38(5):757-63. PubMed ID: 21718951
[TBL] [Abstract][Full Text] [Related]
10. Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid.
Elisei R; Vivaldi A; Ciampi R; Faviana P; Basolo F; Santini F; Traino C; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2006 Jun; 91(6):2389-95. PubMed ID: 16537683
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter.
Braiden V; Nagayama Y; Iitaka M; Namba H; Niwa M; Yamashita S
Endocrinology; 1998 Sep; 139(9):3996-9. PubMed ID: 9724055
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.
Cho JY; Shen DH; Yang W; Williams B; Buckwalter TL; La Perle KM; Hinkle G; Pozderac R; Kloos R; Nagaraja HN; Barth RF; Jhiang SM
Gene Ther; 2002 Sep; 9(17):1139-45. PubMed ID: 12170377
[TBL] [Abstract][Full Text] [Related]
13. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
14. Construction of gene therapy vectors targeting thyroid cells: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the cyclic adenosine 3',5'-monophosphate pathway and demonstration of activity in follicular and anaplastic thyroid carcinoma cells.
Kitazono M; Chuman Y; Aikou T; Fojo T
J Clin Endocrinol Metab; 2001 Feb; 86(2):834-40. PubMed ID: 11158054
[TBL] [Abstract][Full Text] [Related]
15. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
16. In vivo sodium iodide symporter gene therapy of prostate cancer.
Spitzweg C; Dietz AB; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
Gene Ther; 2001 Oct; 8(20):1524-31. PubMed ID: 11704812
[TBL] [Abstract][Full Text] [Related]
17. Approaches to gene therapy with sodium/iodide symporter.
Spitzweg C; Morris JC
Exp Clin Endocrinol Diabetes; 2001; 109(1):56-9. PubMed ID: 11573142
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
Castro MR; Bergert ER; Goellner JR; Hay ID; Morris JC
J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
[TBL] [Abstract][Full Text] [Related]
19. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
Mitrofanova E; Unfer R; Vahanian N; Link C
Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
[TBL] [Abstract][Full Text] [Related]
20. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.
D'Agostino M; Sponziello M; Puppin C; Celano M; Maggisano V; Baldan F; Biffoni M; Bulotta S; Durante C; Filetti S; Damante G; Russo D
J Mol Endocrinol; 2014 Apr; 52(2):121-31. PubMed ID: 24353283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
